Prescription Drug Spending

Exploring Transparency-Rx’s pharmacy benefit manager partners

March 18, 2024 - Transparency-Rx is a recently launched organization of transparent pharmacy benefit managers working towards addressing the ongoing challenges with pharmacy benefit managers (PBMs) that have hindered access to care and significantly increased healthcare spending. “We just launched in September last year as a formal business coalition. Our goal is really to highlight to Congress...

Read More


More Articles

Combating Specialty Drug Challenges in the Pharmaceutical Industry

by Editorial Staff

The pharmaceutical industry has witnessed a significant rise in the utilization of specialty drugs in recent years, prompting a need for improved cost management and a streamlined patient experience. Specialty drugs, characterized by their...

The Importance of Accurately Measuring the Value of New Medications

by Veronica Salib

Last month, No Patient Left Behind, an American nonprofit organization pushing for healthcare reform in the United States to make drugs more affordable, published a report assessing the accuracy and utility of current cost-effectiveness...

How New Platforms Are Saving Patients $4 Billion on Prescription Drugs

by Veronica Salib

Today, Visory Health announced that it is ranked the fourth-largest prescription discount card in the United States, based on an analysis from IQVIA. The company revealed that it has saved 3.25 million...

CMS Announces First Drugs for Medicare Price Negotiations

by Veronica Salib

Kicking off the much-awaited drug price negotiations, the United States Centers for Medicare and Medicaid Services (CMS) and the Department of Health and Human Services (HHS) — under authority...

Biopharmaceutical Leaders Challenge the IRA’s Innovation Implications

by Veronica Salib

On the first day of the 2023 World Medical Innovation Forum (WMIF), sponsored by Mass General Brigham Hospital and Bank of America, biopharmaceutical leaders convened a panel to challenge the Inflation Reduction Act’s (IRA)...

How Inflation, Competition, Biosimilars Affect Prescription Drug Costs

by Editorial Staff

As the inflation rate continues to rise, the healthcare industry — like every other industry — is taxed with extraordinarily high costs. Rising drug prices have caused increased healthcare expenditures and out-of-pocket costs....

High Prescription Drug Costs Lead Older Patients to Ration Medication

by Veronica Salib

While not a new concept, drug rationing across the United States has become an increasingly critical issue. In another tale about the dangers of high prescription drug costs, researchers published an...

Lilly Announces Mounjaro’s Weight Loss Success in Recent Clinical Trial

by Veronica Salib

In an announcement issued earlier this year, Eli Lilly is celebrating the success of Mounjaro in achieving 15.7% weight loss across 72 weeks for obese or overweight adults with type 2 diabetes (T2D)....

Eli Lilly Cuts Insulin Prices and Caps Monthly Out-of-Pocket Costs

by Veronica Salib

On Wednesday, March 1, 2023, Eli Lilly, a major insulin manufacturer in the United States, announced that it would cut its insulin prices by 70% and cap out-of-pocket costs to $35 per month. By the end...

Analyzing 2023 Drug List Price Increases by Pharmaceutical Companies

by Veronica Salib

In January of this year, 46brooklyn, an Ohio-based nonprofit focusing on drug pricing data in the United States, revealed its annual drug pricing data report for 2023. The organization uses and analyzes proprietary data to help shed light...

Legalizing Recreational Cannabis May Reduce Some Opioid Distribution

by Veronica Salib

Recreational cannabis availability through state-level legalization may contribute to reduced rates of opioid distribution, opioid use disorder (OUD), and overdose. As the opioid epidemic has evolved...

Flexible Prescribing Did Not Increase Buprenorphine Overdose Deaths

by Veronica Salib

Despite common misconceptions, researchers published an article in JAMA Network Open noting that buprenorphine overdose-related deaths did not increase during the COVID-19 pandemic when providers were...

Preventing Prescription Drug Fraud

by Veronica Salib

The National Center for Drug Abuse Statistics (NCDAS) notes that approximately 6% of people over 12 in the United States abuse prescription drugs annually, amounting to 16 million people. Additionally, about two million people who abuse...

Prescription Drug Manufacturer Pre-Rebate Costs Skyrocket

by Samantha McGrail

From 2015 to 2019, median prescription drug manufacturer pre-rebate costs per covered life (PCL) increased by 68.1% for individual plans, 44.9% for small group plans, and 23.9% for large group plans,...

AMA Supports Biden’s Medicare Proposal, Prescription Drug Policies

by Samantha McGrail

The American Medical Association (AMA) recently strongly supported the Biden Administration's proposal for Medicare Advantage (MA) and prescription drug benefit policies in an official letter. In...

Top-Selling Medicare Part D Prescription Drugs in Recent Years

by Samantha McGrail

All Medicare plans must cover a wide range of prescription drugs, including most drugs in certain protected classes. But Medicare Part D plans must cover all or substantially all drugs in six...

Cosette Acquires 8 Prescription Medications from Daiichi Sankyo

by Samantha McGrail

Cosette Pharmaceuticals recently acquired US sales and distribution rights to eight prescription medications from Daiichi Sankyo Company and its affiliates. Under the 30-month transition agreement,...

Marketing Strategies to Boost Access to Prescription Medications

by Samantha McGrail

The pharmaceutical supply chain is the means through which prescription medications are manufactured and delivered to patients. There are many ways that patients can obtain a prescription,...

Biden Administration Unveils Plan to Lower Prescription Drug Prices

by Samantha McGrail

HHS Secretary Xavier Becerra recently released a comprehensive plan to lower prescription drug prices. The Drug Pricing Plan, part of a broader initiative from Joe Biden’s Executive Order on...

Recent Articles